50 In August 2025, the US Food and Drug Administration approved semaglutide to treat MASH in adults with moderate-to-advanced fibrosis
Approved GLP-1 Agonists for Weight Loss Currently, there are two GLP-1R agonists approved for the treatment of obesity, Saxenda (liraglutide) and Wegovy (semaglutide) , both developed by Novo Nordisk and approved by the FDA in 2014 and 2021, respectively
10.1371/journal.pone.0081640 176 YangL
If muscle symptoms are severe or persistent despite these interventions, clinicians should consider laboratory evaluation including creatine kinase, comprehensive metabolic panel with separate magnesium and calcium testing, thyroid function tests, vitamin D levels, and vitamin B12 levels to exclude alternative diagnoses
Extensive animal studies have demonstrated its remarkable ability to accelerate the healing of diverse wounds, including those affecting muscles, tendons, and ligaments